Related Experiment Video

Updated: Mar 12, 2026

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
14:56

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies

Published on: May 6, 2022

5.3K

Expression and clinical significance of obesity-associated gene STEAP4 in obese children

H M Xu1, Y Z Cui2, W G Wang3

  • 1Department of Emergency Medicine, Children's Hospital of Kaifeng City, Kaifeng, China huiminxucn@163.com.

Genetics and Molecular Research : GMR
|November 4, 2016
PubMed

Insights

STEAP4 gene expression is significantly lower in obese children

Area of Science:

  • Pediatric Endocrinology
  • Molecular Biology
  • Obesity Research

Background:

  • Childhood obesity is a growing global health concern.
  • Obesity is associated with metabolic and cardiovascular complications.
  • The role of specific genes like STEAP4 in childhood obesity requires further investigation.

Purpose of the Study:

  • To investigate the expression of the STEAP4 gene in obese children.
  • To determine the clinical significance of STEAP4 in relation to metabolic parameters and inflammation.
  • To explore STEAP4 as a potential therapeutic target for childhood obesity.

Main Methods:

  • Recruited 53 obese children and 33 healthy controls.
  • Measured STEAP4 mRNA and protein levels in adipose tissue using RT-PCR and ELISA.
  • Analyzed correlations between STEAP4 expression and blood pressure, lipids, glucose, and inflammatory markers.

Main Results:

  • Obese children had significantly lower STEAP4 mRNA and protein levels compared to controls.
  • Obese children exhibited elevated blood pressure, lipids, glucose, and inflammatory markers (IL-6, TNF-α), with lower HDL.
  • STEAP4 expression was negatively correlated with adverse metabolic and inflammatory markers and positively with HDL.

Conclusions:

  • STEAP4 is downregulated in the adipose tissue of obese children.
  • Reduced STEAP4 expression is linked to key metabolic and inflammatory disturbances in childhood obesity.
  • STEAP4 may serve as a potential biomarker and therapeutic target for childhood obesity management.

More Related Videos

Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker13:26

Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker

Published on: March 31, 2018

10.4K
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.9K

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
262
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
325
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.8K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
342